A carregar...
Inhibition of SMYD2 Sensitized Cisplatin to Resistant Cells in NSCLC Through Activating p53 Pathway
The protein lysine methyltransferase SMYD2 has recently emerged as a new enzyme modulate gene transcription or signaling pathways, and involved into tumor progression. However, the role of SMYD2 in drug resistant is still not known. Here, we found that inhibition of SMYD2 by specific inhibitor could...
Na minha lista:
| Publicado no: | Front Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6498871/ https://ncbi.nlm.nih.gov/pubmed/31106145 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00306 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|